Hannelien Verbeke

545 total citations
9 papers, 424 citations indexed

About

Hannelien Verbeke is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hannelien Verbeke has authored 9 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Hannelien Verbeke's work include Chemokine receptors and signaling (8 papers), Immunotherapy and Immune Responses (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Hannelien Verbeke is often cited by papers focused on Chemokine receptors and signaling (8 papers), Immunotherapy and Immune Responses (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Hannelien Verbeke collaborates with scholars based in Belgium, Saudi Arabia and Germany. Hannelien Verbeke's co-authors include Sofie Struyf, Jo Van Damme, Geneviève Laureys, Ghislain Opdenakker, Paul Proost, Mieke Gouwy, Sam Noppen, Nele Berghmans, Karel Geboes and Ahmed M. Abu El‐Asrar and has published in prestigious journals such as The Journal of Immunology, Journal of Leukocyte Biology and Cancer Letters.

In The Last Decade

Hannelien Verbeke

9 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannelien Verbeke Belgium 9 234 188 126 62 47 9 424
Joyce Setsuda United States 10 297 1.3× 290 1.5× 177 1.4× 78 1.3× 42 0.9× 11 658
Bjoern Schuster Czechia 4 185 0.8× 206 1.1× 75 0.6× 32 0.5× 55 1.2× 9 379
Rocco Alfredo Satriano Italy 12 249 1.1× 142 0.8× 105 0.8× 43 0.7× 27 0.6× 20 509
Yoon Lee South Korea 10 252 1.1× 398 2.1× 126 1.0× 40 0.6× 29 0.6× 13 573
Christelle P El-Haibi United States 7 245 1.0× 152 0.8× 179 1.4× 80 1.3× 19 0.4× 11 487
Fanélie Jouenne France 10 175 0.7× 121 0.6× 197 1.6× 29 0.5× 34 0.7× 39 421
Christopher Eichman United States 10 117 0.5× 300 1.6× 187 1.5× 44 0.7× 50 1.1× 12 565
Giulia Spallone Italy 12 136 0.6× 218 1.2× 237 1.9× 72 1.2× 23 0.5× 27 609
William K. Witmer United States 7 339 1.4× 187 1.0× 136 1.1× 38 0.6× 19 0.4× 7 635
Hedda H. van Ravenswaay Claasen Netherlands 7 154 0.7× 180 1.0× 127 1.0× 43 0.7× 21 0.4× 10 401

Countries citing papers authored by Hannelien Verbeke

Since Specialization
Citations

This map shows the geographic impact of Hannelien Verbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannelien Verbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannelien Verbeke more than expected).

Fields of papers citing papers by Hannelien Verbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannelien Verbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannelien Verbeke. The network helps show where Hannelien Verbeke may publish in the future.

Co-authorship network of co-authors of Hannelien Verbeke

This figure shows the co-authorship network connecting the top 25 collaborators of Hannelien Verbeke. A scholar is included among the top collaborators of Hannelien Verbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannelien Verbeke. Hannelien Verbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lavie, Muriel, Sofie Struyf, Rauf Bhat, et al.. (2012). Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment. Cancer Immunology Immunotherapy. 61(11). 2113–2123. 49 indexed citations
2.
Verbeke, Hannelien, Sofie Struyf, Nele Berghmans, et al.. (2011). Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis. Cancer Letters. 302(1). 54–62. 47 indexed citations
3.
Verbeke, Hannelien, Sofie Struyf, Geneviève Laureys, & Jo Van Damme. (2011). The expression and role of CXC chemokines in colorectal cancer. Cytokine & Growth Factor Reviews. 22(5-6). 345–358. 108 indexed citations
5.
Struyf, Sofie, Sam Noppen, Tamara Loos, et al.. (2009). Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR4. The Journal of Immunology. 182(1). 666–674. 76 indexed citations
6.
Gouwy, Mieke, Sofie Struyf, Hannelien Verbeke, et al.. (2009). CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8. Journal of Leukocyte Biology. 86(3). 671–680. 24 indexed citations
7.
El‐Asrar, Ahmed M. Abu, Sofie Struyf, Hannelien Verbeke, Jo Van Damme, & Karel Geboes. (2009). Circulating bone‐marrow‐derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmologica. 89(3). 222–228. 37 indexed citations
8.
Qiu, Zheng, Chris Dillen, Jialiang Hu, et al.. (2009). Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology. 214(9-10). 835–842. 36 indexed citations
9.
Vandercappellen, Jo, Sam Noppen, Hannelien Verbeke, et al.. (2007). Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells. Journal of Leukocyte Biology. 82(6). 1519–1530. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026